Charles River Laboratories International, Inc.

NYSE:CRL

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

United States

Market Cap

USD 7.33 B

Share Price

USD 148.93

Avg Daily Volume

989,171

Change (1 day)

0.13%

Change (1 year)

-25.89%

Change (YTD)

-19.32%

Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 28, 2025: -2.01%

Charles River Laboratories International, Inc. Return on Equity (ROE) is -2.01% for the Trailing 12 Months (TTM) ending June 28, 2025, a -116.58% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 29, 2024 was 12.11%.
Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 25, 2022 was 17.35%, a -6.75% change year over year.
Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending June 26, 2021 was 18.61%, a 12.66% change year over year.